User profiles for Jamshed B. Bomanji
Jamshed BomanjiDr Verified email at uclh.nhs.uk Cited by 14026 |
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG
I Kayani, JB Bomanji, A Groves… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND. The aim was to assess the relevant distribution of the novel PET tracer 68
Ga‐DOTATATE in neuroendocrine tumors (NETs) with combined positron emission …
Ga‐DOTATATE in neuroendocrine tumors (NETs) with combined positron emission …
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
I Virgolini, V Ambrosini, JB Bomanji, RP Baum… - European journal of …, 2010 - Springer
The aim of these guidelines is to assist nuclear medicine physicians in recommending,
performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging …
performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging …
A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors
Our purpose was to compare the performance of 68 Ga-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic
acid-d-Phe 1 ,Tyr 3 -octreotate (DOTATATE), a novel selective …
acid-d-Phe 1 ,Tyr 3 -octreotate (DOTATATE), a novel selective …
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors
Somatostatin receptor PET tracers such as [ 68 Ga-DOTA,1-Nal 3 ]-octreotide ( 68 Ga-DOTANOC)
and [ 68 Ga-DOTA,Tyr 3 ]-octreotate ( 68 Ga-DOTATATE) have shown promising …
and [ 68 Ga-DOTA,Tyr 3 ]-octreotate ( 68 Ga-DOTATATE) have shown promising …
177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma
JE Gains, JB Bomanji, NL Fersht… - Journal of Nuclear …, 2011 - Soc Nuclear Med
This study tested the principle that 68 Ga-DOTATATE PET/CT may be used to select children
with primary refractory or relapsed high-risk neuroblastoma for treatment with 177 Lu-…
with primary refractory or relapsed high-risk neuroblastoma for treatment with 177 Lu-…
Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging
…, SF Hain, N Stevens, S Daw, A Shankar, JB Bomanji… - Radiology, 2010 - pubs.rsna.org
Purpose To compare the diagnostic performance of rapid whole-body anatomic magnetic
resonance (MR) staging of pediatric and adolescent lymphoma to an enhanced positron …
resonance (MR) staging of pediatric and adolescent lymphoma to an enhanced positron …
Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies
…, A Boutsiadis, J Dickson, JB Bomanji - Parkinsonism & related …, 2012 - Elsevier
PURPOSE: A systematic meta-analysis of published studies on the diagnostic accuracy of
presynaptic dopaminergic imaging with 123 I-FP-CIT (DaTSCAN) in dementia with Lewy …
presynaptic dopaminergic imaging with 123 I-FP-CIT (DaTSCAN) in dementia with Lewy …
Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma
…, I Kayani, M Caplin, S Mahmood, JB Bomanji - European journal of …, 2010 - Springer
Purpose This was a retrospective study to detect and map the extent of disease in recurrent
medullary thyroid carcinoma (MTC) using the novel PET somatostatin analogue 68 Ga-…
medullary thyroid carcinoma (MTC) using the novel PET somatostatin analogue 68 Ga-…
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis
…, A Almuhaideb, JB Bomanji - Journal of Nuclear …, 2011 - Soc Nuclear Med
The aim of our study was to evaluate prospectively the diagnostic performance and prognostic
significance of 18 F-FDG PET/CT in comparison with 123 I-metaiodobenzylguanidine ( …
significance of 18 F-FDG PET/CT in comparison with 123 I-metaiodobenzylguanidine ( …
[HTML][HTML] Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of 18F-FDG PET and …
The major challenge in pre-surgical epileptic patient evaluation is the correct identification
of the seizure onset area, especially in MR-negative patients. In this study, we aimed to: (1) …
of the seizure onset area, especially in MR-negative patients. In this study, we aimed to: (1) …